March 6, 2025Circulation ReportsOpen Access

Efficacy and Safety of Sodium-Glucose Cotransporter 2 Inhibitors for Patients With Heart Failure and Low Body Mass Index

View Full Paper

Ask AI

Bookmark

Abstract

Background: . Methods and Results: groups (85.4% vs. 84.6%; log-rank P=0.869). Conclusions: SGLT2i are feasibly effective and well-tolerated drugs, even for patients with low BMI.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Hatamura et al. (2025) studied this question.

synapsesocial.com/papers/6a077dc6b152628b468b350d https://doi.org/10.1253/circrep.cr-25-0008

View Full Paper

Ask AI

Bookmark

Abstract

Background: . Methods and Results: groups (85.4% vs. 84.6%; log-rank P=0.869). Conclusions: SGLT2i are feasibly effective and well-tolerated drugs, even for patients with low BMI.